AIM2 also played an oncogenic role to regulate the expression of the cell cycle proteins cyclinB1 and cDC2 through the AIM2/IL-1β/STAT3 signaling pathway, thereby regulating NSCLC cell cycle progression (50). The gene discussed is AIM2; the disease is non-small cell lung carcinoma.